A patient with congestive heart failure has completed a transfusion and is complaining of shortness of breath. What drug do you consider administering?

In the context of a patient with congestive heart failure (CHF) who has completed a transfusion and is now experiencing shortness of breath, administering Lasix IV is particularly appropriate. Lasix, a loop diuretic, plays a crucial role in managing fluid overload, which is a common issue in CHF patients. When congestive heart failure worsens or is exacerbated, it can lead to pulmonary congestion and edema, resulting in symptoms such as shortness of breath.

By administering Lasix, you facilitate the removal of excess fluid from the body through increased urine output. This action not only alleviates symptoms of dyspnea but also helps reduce the workload on the heart, thereby improving overall hemodynamic status.

In contrast, other options may not directly address the underlying issue associated with fluid overload in CHF. Nitroglycerin is primarily used for angina or myocardial ischemia and may not be the first choice for fluid management. Albuterol is a bronchodilator, useful in treating bronchospasm but not indicated for fluid overload in CHF. Prednisone, a corticosteroid, can have anti-inflammatory effects but does not serve to resolve the immediate concerns related to fluid retention or pulmonary issues in this scenario. Therefore, Lasix